ZBPro Diagnostic (Version 2.0)
Zbeats, Inc. · Decision date Sep 11, 2026
What did the FDA decide?
FDA's 510(k) record K261580 covers ZBPro Diagnostic (Version 2.0), submitted by Zbeats, Inc. of Stony Brook, New York, with Zaliance Medical Solutions, LLC listed as correspondent. The device falls under the classification name Electrocardiograph, Ambulatory, With Analysis Algorithm, regulation number 870.2800, product code MLO, in the Cardiovascular specialty and review panel. The application was received on 05/13/2026 and recorded as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan.
On 09/11/2026, FDA recorded a decision of Substantially Equivalent (SESE), which for a 510(k) means clearance to market, not premarket approval. The record does not describe the specific components, algorithm changes, or performance data behind Version 2.0, and no summary statement is present in the public information, so the basis for the equivalence determination remains unknown from this source.
The public record also does not identify a predicate device or summarize any clinical evidence, so the scope of what was cleared should be read from the FDA documents rather than inferred here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261580
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Zbeats, Inc.
- Product code
- MLO
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Electrocardiograph, Ambulatory, With Analysis Algorithm.
- Applicant
- Zbeats, Inc.
- Product code
- MLO
- FDA device class
- 2
FDA decision timeline
K261580 received
Application receipt date recorded by FDA.
K261580 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zbeats, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Stony Brook, NY
Sources and methodology
- Original FDA record: K261580
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records